Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-FAPI-GP-01
- Development stage
- Unknown
- Lead developer
- Chengdu Shetai Medical Technology
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
- Administration
- Intravenous
01
Overview
68Ga-FAPI-GP-01 is a novel radiopharmaceutical imaging agent developed for positron emission tomography (PET) imaging of malignant solid tumors. It consists of a fibroblast activation protein (FAP) targeting ligand labeled with the positron-emitting isotope Gallium-68 ($^{68}$Ga). The tracer specifically binds to fibroblast activation protein alpha, which is highly overexpressed on cancer-associated fibroblasts (CAFs) within the stroma of various solid malignancies, while showing minimal expression in normal adult tissues. Developed by the Affiliated Hospital of Guilin Medical University, 68Ga-FAPI-GP-01 is being investigated for its ability to detect tumor lesions with high sensitivity and favorable tumor-to-background ratios, potentially offering diagnostic advantages over conventional imaging tracers like 18F-FDG in specific cancer types.
- Other names
- [68Ga]Ga-FAPI-GP-0168Ga-labeled FAPI-GP-01
02
Targets
FAP (Fibroblast activation protein alpha)
Beyond the preview
Go deeper on 68Ga-FAPI-GP-01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 68Ga-FAPI-GP-01.